epinephrine and hemostat powder in bur

Phase 3

• Conditions: Burn.; burn; T00.2

• Registration Number: IRCT20230517058217N1
• Lead Sponsor: Zanjan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 June 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 108

Inclusion Criteria

Thermal burn patients with total body surface area (TBSA) involvement less than 30%

Exclusion Criteria

Coagulopathies
Active malignancies
Autoimmune diseases
Patients who receive corticosteroids daily

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Hemoglobin drop rate. Timepoint: Six hours before surgery and six hours after surgery. Method of measurement: Venous sampling from the brachial vein.